View in EDS HTML Full Text PDF Full Text

A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.

Saved in:
Bibliographic Details
Title: A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.
Authors: Besson, Juliette1 (AUTHOR) Juliette.Besson@hotmail.com, Audran, Régine2 (AUTHOR), Karlen, Maxime1 (AUTHOR), Miauton, Alix1 (AUTHOR), Hajjami, Hélène Maby-El3 (AUTHOR), Warpelin-Decrausaz, Loane3,4 (AUTHOR), Sene, Loredana3 (AUTHOR), Schaufelberger, Sylvain5 (AUTHOR), Faivre, Vincent5 (AUTHOR), Faouzi, Mohamed6 (AUTHOR), Hartley, Mary-Anne1 (AUTHOR), Spertini, François2 (AUTHOR), Genton, Blaise1 (AUTHOR)
Source: BMC Infectious Diseases. 4/16/2025, Vol. 25 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712334
DOI:10.1186/s12879-025-10844-3